Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharma May See Brighter Enforcement Environment After US Justice Department Policy Changes

Executive Summary

Policy revisions on individual liability for corporate misconduct, noncompliance with agency guidance documents and dismissal of False Claims Act cases suggest a greater willingness by DoJ leadership to reconsider arguments often raised by life sciences companies, attorneys say at a Food and Drug Law Institute conference.


Advertisement

Related Content

US False Claims Act Dismissal Motions Are Executive Branch Over-Reach, Whistleblowers Say
False Claims Act: US Justice Department Gives Pharma Early Christmas Present
US Enforcement 2019: Compounding, Opioids Top Priorities But Beware Of REMS Violations, Too
Actelion Is Third Company To Settle Charity Co-Pay Kickback Claims With DOJ
Gilead False Claims Case: Government Opposes Supreme Court Review But Thinks Suit Should Be Tossed
From White House To White Oak: US FDA Taps Stacy Cline Amin For Chief Counsel Post
Government Pharma Investigations Target Pricing, Opioids, Trade Practices
US FDA’s Lowell Schiller Steps In As Acting Chief Counsel When Rebecca Wood Departs In July
US FDA May Clarify When Execs Can Be Criminally Prosecuted Under Park Doctrine
Does Former Warner Chilcott Exec’s Arrest Portend More Prosecutions?

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS124440

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel